Catalyst Biosciences' Merger

Catalyst Biosciences raised a round of funding on March 05, 2015. Investors include Targacept.

Catalyst Biosciences is developing next generation biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform …

Articles about Catalyst Biosciences' Merger: